
Overview
Global Blood Glucose Monitoring System Market
Blood Glucose Monitoring System Market: Overview
According to Custom Market Insights (CMI), The Global Blood Glucose Monitoring System Market was valued at USD 23.45 Billion in the year 2025 and it is expected to grow to USD 59.87 Billion by the year 2034 growing at a compound annual growth rate of 10.75% during the forecast period 2025 and 2034.
The increasing cases of patients who have diabetes have boosted the market for glucose monitoring systems. The rapidly increasing prevalence of type 2 diabetes has helped the market for insulin grow greatly. This has to be supported by the blood glucose monitoring system, which becomes an essential factor in checking glucose levels before administering insulin. Constant monitoring is required in patients with critical conditions who are on anti diabetic medicines. The huge client base in the market suffering from diabetes and other blood glucose related disorders has considerably boosted the markets size.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.custommarketinsights.com/request-for-free-sample/?reportid=18790
Blood Glucose Monitoring System Market: Growth Drivers
The huge number of patients available in the market due to the increasing prevalence of cholesterol and obesity has helped the market record considerable revenue, and hes foreseen to continue similarly during the forecast period as well. The increasing demand for advanced technologies and efficient monitoring systems to manage patients blood glucose levels has helped the blood glucose monitoring system market record considerable revenue.
Key market players are investing in extensive research and development programs to introduce cheaper options for monitoring blood glucose. Faulty lifestyle practices followed by the people and increasing stress resulting from busy lifestyle practices and improper work life balance have greatly boosted the market size. These reasons emerge as the driving forces for the blood glucose monitoring system market during the forecast period.
Report URL: https://www.custommarketinsights.com/report/blood-glucose-monitoring/
Blood Glucose Monitoring System Market: Regional Analysis
The region of North America has emerged as the largest market for blood glucose monitoring systems owing to the huge number of people suffering from blood glucose disorders and diabetes due to the rapid changes in lifestyle due to the increasing stress and workload on the people.
A huge number of people belonging to the geriatric population reside in this region who suffer from diabetes as a common disorder and need constant monitoring to administer the required dosage of medicines and insulin. It becomes impossible for these people to visit the healthcare sector, so a portable blood glucose monitoring system becomes an essential factor for them.
The people belonging to the European nations also have a huge tendency to suffer from diabetes owing to faulty lifestyle practices and increasing amounts of fast food among youngsters, which behave as a major factor for the causation of diabetes and hence the requirement for blood glucose monitoring systems has increased. The advanced healthcare facilities the government provides have also boosted the need for constant blood glucose monitoring systems in the market.
The Asia Pacific region has emerged as the next largest market, with a huge client base suffering from diabetes. Rapidly emerging healthcare sectors and developing economy has boosted the disposable income available to the people. Rapidly increasing awareness among the people regarding advanced technologies available in the market to manage their blood glucose levels has boosted the demand for blood glucose monitoring systems.
Blood Glucose Monitoring System Market: Recent Developments
- In March 2021 Accu check was introduced by F Hoffmann la Roche with a view to monitor blood glucose levels instantly which will be directly connected to an app known as mySugr.
Key Players:
- Abbott Laboratories
- Medtronic plc
- Hoffmann La Roche Ltd.
- Ascensia Diabetes Care
- Dexcom Inc.
- Sanofi
- Novo Nordisk
- Insulet Corporation
- Ypsomed Holdings
- Glysens Incorporated
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.custommarketinsights.com/request-for-free-sample/?reportid=18790
The global Blood Glucose Monitoring System market is segmented as follows:
By Device
- Self monitoring blood glucose system
- Continuous glucose monitoring system
By Modality
- Non wearable
- Wearable
By Type
- Invasive
- Non invasive
By Patient Type
- Type 1 diabetes
- Type 2 diabetes
By Distribution Channel
- Retail sales
- Institutional sales
On the basis of Geography
North America
- The U.S.
- Canada
- Mexico
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Browse Other Custom Market Insights coverage of the Global MEDICAL DEVICES Industry
Details
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
Pricing
Vendor refund policy
No Refund Policy
How can we make this page better?
Legal
Vendor terms and conditions
Content disclaimer
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
Global Blood Glucose Monitoring System Market | All historical revisions | All future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
